ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 657 filers reported holding ISHARES TR in Q2 2019. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,999,879 | +0.0% | 14,570 | 0.0% | 0.05% | -2.0% |
Q1 2024 | $1,999,296 | +0.3% | 14,570 | -0.7% | 0.05% | -5.7% |
Q4 2023 | $1,992,920 | +9.8% | 14,670 | -1.1% | 0.05% | +1.9% |
Q3 2023 | $1,814,540 | -2.5% | 14,838 | +1.2% | 0.05% | 0.0% |
Q2 2023 | $1,861,743 | -5.5% | 14,664 | -3.9% | 0.05% | -10.3% |
Q1 2023 | $1,970,595 | -7.4% | 15,257 | -5.9% | 0.06% | -12.1% |
Q4 2022 | $2,127,685 | +2.9% | 16,206 | -8.3% | 0.07% | -7.0% |
Q3 2022 | $2,068,000 | -3.1% | 17,681 | -2.5% | 0.07% | +1.4% |
Q2 2022 | $2,134,000 | -11.8% | 18,140 | -2.3% | 0.07% | +1.4% |
Q1 2022 | $2,420,000 | -16.0% | 18,572 | -1.6% | 0.07% | -14.8% |
Q4 2021 | $2,881,000 | -5.5% | 18,881 | +0.1% | 0.08% | -25.7% |
Q3 2021 | $3,049,000 | -1.5% | 18,859 | -0.3% | 0.11% | -2.7% |
Q2 2021 | $3,095,000 | +6.2% | 18,909 | -2.3% | 0.11% | -1.8% |
Q1 2021 | $2,915,000 | +1.8% | 19,362 | +2.4% | 0.11% | -2.6% |
Q4 2020 | $2,864,000 | +0.6% | 18,906 | -10.0% | 0.12% | -9.3% |
Q3 2020 | $2,846,000 | +5.1% | 21,012 | +6.1% | 0.13% | -5.1% |
Q2 2020 | $2,707,000 | +26.1% | 19,802 | -0.6% | 0.14% | +3.0% |
Q1 2020 | $2,147,000 | -8.4% | 19,931 | +2.4% | 0.13% | +10.0% |
Q4 2019 | $2,344,000 | +31.5% | 19,455 | +8.6% | 0.12% | +20.0% |
Q3 2019 | $1,782,000 | -9.4% | 17,909 | -2.6% | 0.10% | -10.7% |
Q2 2019 | $1,967,000 | -4.5% | 18,379 | -0.2% | 0.11% | -8.9% |
Q1 2019 | $2,060,000 | +16.2% | 18,424 | +0.2% | 0.12% | +4.2% |
Q4 2018 | $1,773,000 | -19.9% | 18,392 | +1.3% | 0.12% | -8.5% |
Q3 2018 | $2,214,000 | +6.2% | 18,155 | -4.3% | 0.13% | -3.0% |
Q2 2018 | $2,084,000 | -3.1% | 18,970 | -5.9% | 0.13% | -2.9% |
Q1 2018 | $2,151,000 | -6.1% | 20,157 | -6.0% | 0.14% | -1.4% |
Q4 2017 | $2,291,000 | -4.2% | 21,452 | +199.2% | 0.14% | -10.3% |
Q3 2017 | $2,392,000 | +6.3% | 7,169 | -1.2% | 0.16% | +4.0% |
Q2 2017 | $2,250,000 | -14.7% | 7,259 | -19.3% | 0.15% | -15.3% |
Q1 2017 | $2,638,000 | +12.1% | 8,994 | +1.4% | 0.18% | +8.6% |
Q4 2016 | $2,353,000 | -21.3% | 8,866 | -14.2% | 0.16% | -25.7% |
Q3 2016 | $2,991,000 | +70.3% | 10,331 | +51.4% | 0.22% | +66.4% |
Q2 2016 | $1,756,000 | +2.8% | 6,823 | +4.2% | 0.13% | -3.0% |
Q1 2016 | $1,708,000 | -14.0% | 6,551 | +11.7% | 0.14% | -17.7% |
Q4 2015 | $1,985,000 | +14.7% | 5,865 | +2.9% | 0.16% | +8.6% |
Q3 2015 | $1,730,000 | -16.6% | 5,702 | +1.4% | 0.15% | -7.4% |
Q2 2015 | $2,075,000 | +267.3% | 5,625 | +241.9% | 0.16% | +262.2% |
Q1 2015 | $565,000 | +17.0% | 1,645 | +3.3% | 0.04% | +15.4% |
Q4 2014 | $483,000 | +17.8% | 1,592 | +6.3% | 0.04% | +18.2% |
Q3 2014 | $410,000 | +3.0% | 1,498 | -3.2% | 0.03% | +6.5% |
Q2 2014 | $398,000 | +49.6% | 1,548 | +37.8% | 0.03% | +40.9% |
Q1 2014 | $266,000 | +41.5% | 1,123 | +35.5% | 0.02% | +37.5% |
Q4 2013 | $188,000 | +15.3% | 829 | +6.4% | 0.02% | +6.7% |
Q3 2013 | $163,000 | +3160.0% | 779 | +2586.2% | 0.02% | – |
Q2 2013 | $5,000 | – | 29 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |